Notas de prensa

  • 11 de octubre de 2017
  • 296

Envigo appointment of new business lead consultant further strengthens regulatory consultant team

The company’s unique full service offering for regulatory advice and research bolstered by further investment in consulting expertise

Princeton, NJ, USA October 11, 2017: Envigo has announced the appointment of Dr. Naheed Rehman as new business lead consultant, chemicals – adding further specialist expertise to its dedicated team of regulatory consultants servicing the chemicals industry.

Her appointment brings strategic scientific leadership and additional regulatory insights to the advisory service Envigo supplies to its customers – including across the most recent innovations and emerging global regulations. Naheed has extensive experience in scientific and regulatory fields – especially relating to global chemical regulations, environmental fate, ecotoxicology, environmental sustainability and life cycle analysis.

This latest recruitment initiative builds on five other earlier appointments of experienced regulatory specialists and consultants since last November - bolstering the combined expertise of the advisory service team.

Jimmy O’Connor, Chief Scientific Officer – Crop Protection and Chemical at Envigo commented: “Envigo’s regulatory consultancy offering provides our customers with the value-added benefit of expert advice on regulatory compliance and the high quality research services that they need. We are unique in providing this combined and contextualised service to the chemicals market from a single source.”

He added: “We are delighted to welcome Naheed to the Envigo team and look forward to her considerable experience, expertise and insights being put to valuable use for our customers. Her appointment further evidences Envigo’s commitment to invest in our consulting and advisory services.”

Destacadas

  • Las terapias celulares emergentes son alternativas  prometedoras para tratar el melanoma metastásico  refractario y otros tumores sólidos resistentes

    Patricia Morén

    Las terapias celulares emergentes son alternativas prometedoras para tratar el melanoma metastásico refractario y otros tumores sólidos resistentes

    Leer más
  • El cáncer colorrectal requiere un enfoque multidisciplinar que incluya la economía de la salud y la optimización en gestión clínica para ofrecer una atención al paciente más eficiente

    Maryuri Vargas

    El cáncer colorrectal requiere un enfoque multidisciplinar que incluya la economía de la salud y la optimización en gestión clínica para ofrecer una atención al paciente más eficiente

    Leer más
  • Niveles de vitamina D inferiores a 20 ng/ml podrían estar relacionados con una mayor incidencia de enfermedades cardiovasculares

    Maryuri Vargas

    Niveles de vitamina D inferiores a 20 ng/ml podrían estar relacionados con una mayor incidencia de enfermedades cardiovasculares

    Leer más

Newsletter

Suscríbete para conocer las novedades del mundo farmacéutico y sanitario.

¿Qué es?

FarmaNews pone a disposición de los medios y departamentos de comunicación, un canal para publicar notas de prensa y convocatorias del mundo sanitario y farmacéutico.

Contacto

Avda. Mare de Déu de Lourdes, 108,
08757, Corbera de Llobregat
(Barcelona), España